Authors: Azzolina, O Collina, S Linati, L Anzini, M Cappelli, A Scheideler, MA Sbacchi, M

Citation: O. Azzolina et al., Enantiomers of 2-[(acylamino)ethyl]-1,4-benzodiazepines, potent ligands ofkappa-opioid receptor: Chiral chromatographic resolution, configurational assignment, and biological activity, CHIRALITY, 13(9), 2001, pp. 606-612

Authors: Blaney, FE Raveglia, LF Artico, M Cavagnera, S Dartois, C Farina, C Grugni, M Gagliardi, S Luttmann, MA Martinelli, M Nadler, GMMG Parini, C Petrillo, P Sarau, HM Scheideler, MA Hay, DWP Giardina, GAM

Citation: Fe. Blaney et al., Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity andselectivity in quinoline tachykinin receptor antagonists, J MED CHEM, 44(11), 2001, pp. 1675-1689

Authors: Collina, S Azzolina, O Vercesi, D Sbacchi, M Scheideler, MA Barbieri, A Lanza, E Ghislandi, V

Citation: S. Collina et al., Synthesis and antinociceptive activity of pyrrolidinylnaphthalenes, BIO MED CH, 8(8), 2000, pp. 1925-1930

Authors: Videbaek, C Toska, K Scheideler, MA Paulson, OB Knudsen, GM

Citation: C. Videbaek et al., SPECT tracer [I-123]IBZM has similar affinity to dopamine D2 and D3 receptors, SYNAPSE, 38(3), 2000, pp. 338-342

Authors: Song, XD Crider, AM Cruse, SF Ghosh, D Klein-Stevens, C Liang, L Scheideler, MA Varming, A Softofte, I

Citation: Xd. Song et al., cis- and trans-2,3,3a,4,5,9b-Hexahydro-1H-benz[e]indoles: synthesis and evaluation of dopamine D-2 and D-3 receptor binding affinity, EUR J MED C, 34(6), 1999, pp. 487-503